Merge pull request 'extract: 2024-10-31-cms-vbid-model-termination-food-medicine' (#1263) from extract/2024-10-31-cms-vbid-model-termination-food-medicine into main
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run
This commit is contained in:
commit
c98e1e4da3
3 changed files with 59 additions and 3 deletions
|
|
@ -41,16 +41,22 @@ The claim that budget scoring "systematically" undervalues prevention requires e
|
|||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-11-01-aspe-medicare-anti-obesity-medication-coverage]] | Added: 2026-03-16*
|
||||
*Source: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage | Added: 2026-03-16*
|
||||
|
||||
The CBO vs. ASPE divergence on Medicare GLP-1 coverage provides concrete evidence: CBO projects $35B in additional spending (2026-2034) using budget scoring methodology, while ASPE projects net savings of $715M over 10 years using clinical economics methodology that includes downstream event avoidance. The $35.7B gap between these estimates demonstrates how budget scoring rules structurally disadvantage preventive interventions. CBO uses conservative uptake assumptions and doesn't fully count avoided hospitalizations and disease progression within the 10-year window, while ASPE includes 38,950 CV events avoided and 6,180 deaths avoided. Both are technically correct but answer different questions—budget impact vs. clinical economics.
|
||||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2025-01-01-gimm-hoffman-chw-rct-scoping-review]] | Added: 2026-03-18*
|
||||
*Source: 2025-01-01-gimm-hoffman-chw-rct-scoping-review | Added: 2026-03-18*
|
||||
|
||||
IMPaCT's $2.47 Medicaid ROI within the same fiscal year demonstrates that at least one category of preventive intervention (CHW programs) generates returns fast enough to be captured within annual budget cycles, not just 10-year windows. This suggests the scoring methodology problem may be less severe for interventions with rapid return profiles.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2024-10-31-cms-vbid-model-termination-food-medicine]] | Added: 2026-03-18*
|
||||
|
||||
VBID termination was driven by $2.3B excess costs in CY2021-2022, measured within a short window that could not capture long-term savings from food-as-medicine interventions. CMS cited 'unprecedented' excess costs as justification, demonstrating how short-term cost accounting drives policy decisions even for preventive interventions with strong theoretical long-term ROI.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,36 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 2,
|
||||
"kept": 0,
|
||||
"fixed": 6,
|
||||
"rejected": 2,
|
||||
"fixes_applied": [
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:set_created:2026-03-18",
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:stripped_wiki_link:value-based-care-transitions-stall-at-the-payment-boundary-b",
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:stripped_wiki_link:SDOH-interventions-show-strong-ROI-but-adoption-stalls-becau",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:set_created:2026-03-18",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:stripped_wiki_link:value-based-care-transitions-stall-at-the-payment-boundary-b",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:stripped_wiki_link:federal-budget-scoring-methodology-systematically-undervalue"
|
||||
],
|
||||
"rejections": [
|
||||
"cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.md:missing_attribution_extractor",
|
||||
"food-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-18"
|
||||
}
|
||||
|
|
@ -7,10 +7,14 @@ date: 2024-10-31
|
|||
domain: health
|
||||
secondary_domains: [internet-finance]
|
||||
format: announcement
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [vbid, cms, medicare-advantage, food-as-medicine, payment-policy, supplemental-benefits, ssbci]
|
||||
flagged_for_rio: ["CMS VBID termination is a major payment model policy shift — intersects with Rio's VBC and MA economics analysis"]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-18
|
||||
enrichments_applied: ["federal-budget-scoring-methodology-systematically-undervalues-preventive-interventions-because-10-year-window-excludes-long-term-savings.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -68,3 +72,13 @@ CMS announced termination of the Medicare Advantage Value-Based Insurance Design
|
|||
PRIMARY CONNECTION: The structural misalignment claim in VBC (payment boundary stalls) — this is a new instance where the payment infrastructure for non-clinical intervention is contracting
|
||||
WHY ARCHIVED: Policy event that changes the funding landscape for food-as-medicine — essential context for any claim about FIM scalability or the attractor state toward prevention
|
||||
EXTRACTION HINT: Extract the payment mechanism claim (VBID ends, SSBCI excludes low-income) as a concrete policy-state change. Also flag the MAHA rhetoric vs. funding reality as a cross-domain political economy observation.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- VBID excess costs: $2.3 billion in CY2021, $2.2 billion in CY2022
|
||||
- ~2,000 MA plans participated in VBID at peak
|
||||
- Food/nutrition assistance was the most common VBID supplemental benefit in 2024
|
||||
- 6 of 8 states with active 1115 waivers for food-as-medicine programs were placed under CMS review
|
||||
- VBID termination announced by Biden administration October/November 2024
|
||||
- VBID ends December 31, 2025
|
||||
- SSBCI (replacement pathway) does not allow eligibility based on low income or socioeconomic disadvantage
|
||||
|
|
|
|||
Loading…
Reference in a new issue